DuoResp Spiromax 160 micrograms/4.5 micrograms inhalation powder
Authorisation EU/1/14/920 /001-003 · Teva Pharma B.V.
- Licence holder
- Teva Pharma B.V. (all products →)
- Active substances
- Budesonide, Formoterol fumatrate dihydrate
- Clinical trials
- 15 clinical trials →
- Dosage form
- Inhalation powder
- Route of administration
- Inhalation use
- ATC code
- R03AK07
- First authorised
- 28/04/2014
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Hybrid application (Article 10(3) of Directive No 2001/83/EC)
Budesonide: supply and approvals
37 authorised products on the HPRA list contain Budesonide. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- 3 supply notices, e.g. Cyclocaps Budesonid 200 µg (1 Aug 2025 to 31 Dec 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Formoterol fumatrate dihydrate: supply and approvals
6 authorised products on the HPRA list contain Formoterol fumatrate dihydrate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 20 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
Centralised EU authorisation. This product holds an EU-wide marketing authorisation granted by the European Commission after assessment by the European Medicines Agency, valid in every EU country. Its EU product number is 920. It has been authorised for 12 years (since 28 April 2014). The HPRA list does not say whether it is on sale.
Other medicines with Budesonide in Ireland
35 other products on the HPRA list contain Budesonide, from 10 licence holders; 21 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
Other medicines with Formoterol fumatrate dihydrate in Ireland
5 other products on the HPRA list contain Formoterol fumatrate dihydrate, from 2 licence holders; 2 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Symbicort Turbohaler, 400 micrograms/12 micrograms/inhalation, inhalation powder | AstraZeneca AB | National authorisation (PA) | Marketed |
| Symbicort® Turbohaler; 200 micrograms/6 micrograms/inhalation, inhalation powder | AstraZeneca AB | National authorisation (PA) | Marketed |
| DuoResp Spiromax 320 micrograms/9 micrograms inhalation powder | Teva Pharma B.V. | Centralised EU authorisation | Not stated |
| Oxis Turbohaler 12, inhalation powder | AstraZeneca AB | National authorisation (PA) | Not marketed |
| Oxis Turbohaler 6, inhalation powder | AstraZeneca AB | National authorisation (PA) | Not marketed |
The licence holder
Teva Pharma B.V. holds 155 products on the HPRA list, with 69 different active substances; 100 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.